))
Ep. 20 Recent advances in management of advanced upper GI cancers: Immunotherapy
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on January 27, 2024 09:12 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 397429183 series 3540536
Contenu fourni par Prashant Jambunathan. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Prashant Jambunathan ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
In the first part of this two part episode, we will talk about the role of Pembrolizumab (Keynote 062 for first line, Keynote 181 for second line) and Nivolumab (Checkmate 849) in both, first and later lines, in the management of advanced HER2 negative, gastric and GE junction cancers.
22 episodes
Partager
